HHS Releases 'Wolves in White Coats' Report Alleging Fraudulent Billing in Pediatric Gender Medicine

On August 13, 2026, the U.S. Department of Health and Human Services (HHS) released a commissioned report titled 'Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine.”' The report examines insurance coding practices across 225 healthcare institutions, alleging that providers used proxy or inaccurate diagnosis codes to bill for puberty blockers, cross-sex hormones, and surgeries on minors rather than specific gender dysphoria codes.

Key findings include approximately $50 million in claims for puberty blockers billed under 'unspecified endocrine disorder' diagnoses between 2015 and 2025, and nearly $11 million billed under 'precocious puberty' for patients aged 13-17, an age when natural puberty typically occurs. The report highlights guidance from organizations like WPATH and others encouraging alternative codes, and describes 'captive patients' requiring lifelong medical interventions as a revenue driver. It references prior DOJ settlements, such as one involving Texas Children's Hospital.

HHS referred identified providers to the Department of Justice and its Office of Inspector General for potential federal law violations. The report was accompanied by a short documentary and builds on an earlier HHS evidence review on pediatric gender dysphoria released in November 2025.

Mainstream coverage notes the report's reliance on CMS data, whistleblower accounts, and claims analysis, while acknowledging its contributors' critical stance on gender-affirming care. Official HHS channels, including social media and press releases, have promoted the findings under the current administration.